×
S&P 500   3,808.39 (-0.34%)
DOW   30,965.96 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.86 (+1.03%)
MSFT   259.04 (+1.00%)
META   162.49 (+1.13%)
GOOGL   2,224.55 (-0.70%)
AMZN   108.29 (+0.83%)
TSLA   668.60 (-4.21%)
NVDA   153.12 (-4.19%)
NIO   21.48 (-3.94%)
BABA   115.21 (-1.33%)
AMD   76.63 (-5.14%)
MU   55.39 (-4.27%)
CGC   3.50 (-3.05%)
T   20.81 (+0.97%)
GE   63.50 (-3.61%)
F   11.43 (-3.22%)
DIS   94.84 (-1.13%)
AMC   13.37 (-0.07%)
PFE   50.86 (+0.39%)
PYPL   70.76 (-1.48%)
NFLX   175.91 (-2.05%)
S&P 500   3,808.39 (-0.34%)
DOW   30,965.96 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.86 (+1.03%)
MSFT   259.04 (+1.00%)
META   162.49 (+1.13%)
GOOGL   2,224.55 (-0.70%)
AMZN   108.29 (+0.83%)
TSLA   668.60 (-4.21%)
NVDA   153.12 (-4.19%)
NIO   21.48 (-3.94%)
BABA   115.21 (-1.33%)
AMD   76.63 (-5.14%)
MU   55.39 (-4.27%)
CGC   3.50 (-3.05%)
T   20.81 (+0.97%)
GE   63.50 (-3.61%)
F   11.43 (-3.22%)
DIS   94.84 (-1.13%)
AMC   13.37 (-0.07%)
PFE   50.86 (+0.39%)
PYPL   70.76 (-1.48%)
NFLX   175.91 (-2.05%)
S&P 500   3,808.39 (-0.34%)
DOW   30,965.96 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.86 (+1.03%)
MSFT   259.04 (+1.00%)
META   162.49 (+1.13%)
GOOGL   2,224.55 (-0.70%)
AMZN   108.29 (+0.83%)
TSLA   668.60 (-4.21%)
NVDA   153.12 (-4.19%)
NIO   21.48 (-3.94%)
BABA   115.21 (-1.33%)
AMD   76.63 (-5.14%)
MU   55.39 (-4.27%)
CGC   3.50 (-3.05%)
T   20.81 (+0.97%)
GE   63.50 (-3.61%)
F   11.43 (-3.22%)
DIS   94.84 (-1.13%)
AMC   13.37 (-0.07%)
PFE   50.86 (+0.39%)
PYPL   70.76 (-1.48%)
NFLX   175.91 (-2.05%)
S&P 500   3,808.39 (-0.34%)
DOW   30,965.96 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.86 (+1.03%)
MSFT   259.04 (+1.00%)
META   162.49 (+1.13%)
GOOGL   2,224.55 (-0.70%)
AMZN   108.29 (+0.83%)
TSLA   668.60 (-4.21%)
NVDA   153.12 (-4.19%)
NIO   21.48 (-3.94%)
BABA   115.21 (-1.33%)
AMD   76.63 (-5.14%)
MU   55.39 (-4.27%)
CGC   3.50 (-3.05%)
T   20.81 (+0.97%)
GE   63.50 (-3.61%)
F   11.43 (-3.22%)
DIS   94.84 (-1.13%)
AMC   13.37 (-0.07%)
PFE   50.86 (+0.39%)
PYPL   70.76 (-1.48%)
NFLX   175.91 (-2.05%)

The Top Is In For Infosys 

Thursday, April 14, 2022 | Thomas Hughes
The Top Is In For Infosys 

Infosys Growth Is Priced In 

Infosys (NYSE: INFY) is still growing, it’s still making profits, and it’s still on track to pay a higher dividend than it did last year but the market for the stock has peaked. This is because the growth is more than priced in and sell-side support is waning. In this paradigm, we can expect to see the analysts and institutions add more weight to share prices and possibly turn this top into a full reversal. Trading at 27X its earnings with earnings growth slowing a dividend below 2.0% there is really no reason to be excited about this stock and, if you already own it, plenty of reasons to take profits and move that money somewhere else. 

Infosys Produces Weak Quarter, Guidance Is Weak Too 

Infosys did not have a bad quarter but when it comes to the market it isn’t so much how a company performs but how it performs relative to expectations. When it comes to performance, Infosys, grew revenue by 18.6% YOY to $4.28 billion. When it comes to performance relative to the analyst's expectations the figure is only as expected which was no catalyst for share prices, especially when coupled with weak guidance. Internally, the company’s transition to digital and cloud-based services continues to drive success. Digital revenue increased to 59.2% of the net on a 38.8% CC increase. 

Moving down, the company reported margin contraction which was expected as well, the good news is that margin contraction was only as expected with the operating margin down 300 basis points to 21.5%. This contributed to a 480 basis point decline in FCF and only 12.5% growth on the bottom line. On the bottom line, the $0.18 in GAAP earnings is up YOY but again, provided no catalyst for share prices and there is the guidance to consider as well. 


As for the guidance, the company is expecting to see FY revenue growth in the range of 13% to 15% which is good, but it compares poorly to the analyst consensus which is bad. Worse, the company is not predicting any substantial improvement in the operating margin which leaves the outlook for EPS below consensus as well. In both cases, the guidance is not providing a catalyst for share prices either. 

Analysts Sentiment Wanes, Institutions Shed Infosys 

The institutional activity in Infosys is more or less balanced over the past 12 months but has been tilted in favor of the bears for the last 6. The institutions have been net sellers for the last two quarters shedding about $0.01 billion or about 0.02% of the stock, no large amount, but a headwind nonetheless. And the institutions don’t hold much, only about 15.5%, so there is no underlying base of support ready to hold up prices should they begin to fall. In regards to the analysts, the Marketbeat.com consensus slipped to a firm Hold from Buy over the past year and the price target is falling too. The consensus price target is still 20% above the recent price action but it is down in the 3-mont and 1-month comparison and moving lower in the wake of the guidance update. 

The Technical Outlook: Infosys Topped, A Reversal May Come Next 

The price of Infosys more than tripled in the wake of the pandemic so it is no surprise to see some topping action now. The weekly chart shows a clear Double Top that has the stock in a trading range and in danger of reversal. Key support is at the $1675 level, a break below there would be bearish. Assuming the market does fall below this level, we see price action moving down to $1400 or lower. If price action can maintain support above $1675, we see this stock moving sideways within its current range until something changes in the outlook. 

The Top Is In For Infosys 

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Infosys (INFY)
2.6481 of 5 stars
$18.58+0.7%1.88%26.54Moderate Buy$26.75
Compare These Stocks  Add These Stocks to My Watchlist 

Should you invest $1,000 in Infosys right now?

Before you consider Infosys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Infosys wasn't on the list.

While Infosys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:


Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastHow to Profit In The Bear Market

Today, Kate is joined by a repeat guest, Rob Isbitts of Sungarden Investment Publishing. Rob specializes in ETF portfolios designed to deliver returns in any kind of market condition, including the current bear. In this conversation, Rob gives specific ideas for handling various allocations in your portfolio, and discusses how to approach inverse ETFs.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.